Choline C-11

CHEMBL2095207 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
103.2 g/mol
LogP
-0.4
Phase
4

A radiotracer consisting of radiolabeled choline used in positron emission tomography (PET) imaging to detect recurrent prostate cancer. Cancer cells take up choline at increased rates as a substrate for membrane phospholipid synthesis. This allows detection of metastatic disease, particularly when conventional imaging is negative.

Moleküler Ağırlık

103,1700 g/mol

LogP

-0,40

TPSA

20,20 Ų

Lipinski RO5

Geçer

Terapötik Alanlar

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C[N+](C)([11CH3])CCO.[Cl-]

InChI

InChI=1S/C5H14NO.ClH/c1-6(2,3)4-5-7;/h7H,4-5H2,1-3H3;1H/q+1;/p-1/i1-1;

Molecular Formula

C5H14NO+

HBD / HBA

1 / 1

Döndürülebilir Bağlar

2

Ağır Atomlar

7

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A radiotracer consisting of radiolabeled choline used in positron emission tomography (PET) imaging to detect recurrent prostate cancer. Cancer cells take up choline at increased rates as a substrate for membrane phospholipid synthesis. This allows detection of metastatic disease, particularly when conventional imaging is negative.

Yes, Choline C-11 is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2095207. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 449688. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.